Purchase Order 75N95A24P00079
- Not listed
- This federal contract award to Psomagen Inc., a for-profit manufacturer, provides a Firm Fixed Price purchase order valued at $113,247.00 for the OLINK EXPLORE HT PROCESSING SERVICE. The contract is issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, and will support the institute's research on neurological disorders such as ALS, long COVID, and HIV. The contract requires Psomagen to perform the OLINK Explore HT Biomarker discovery protocol...
- This firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The $23,030 contract is for OLINK HT ANALYSIS services, which likely refers to genomic sequencing and analysis capabilities provided by Psomagen. The contract has an ultimate completion date of July 29, 2025 and was awarded on July 30, 2024...
- This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
- The National Institute on Aging (NIA), a civilian agency within the U.S. government, has awarded a $237,440.00 firm fixed-price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide next-generation sequencing analysis services on post-mortem frontal cortex tissues. The contract has an ultimate completion date of July 31, 2025. This award is not associated with a set-aside program. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a multiomics...
- This is a $24,940 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit manufacturer and genomics/molecular biology services company, for Olink proteomic assays to support the Laboratory of Sickle Cell Genetics and Pathophysiology's research on the relationship between the TTR V122I genetic mutation and its protein variant. The award is not associated with a set-aside program and has an ultimate...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...
- This is a federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., by the National Institute of Allergy and Infectious Diseases (NIAID) to provide other functions for a total ceiling value of $6,000.00. The contract is a firm-fixed price purchase order with an ultimate completion date of October 23, 2013. Psomagen is a multiomics contract laboratory service and data analysis provider that specializes in delivering a wide range of genomic and molecular biology services to...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland. The $180,000 contract has a period of performance ending on May 19, 2025. Psomagen Inc. is a subsidiary of the parent company Macrogen, Inc., which is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. The contract does not have a...
- This $24,940 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency, to Psomagen Inc., a for-profit manufacturer of genomic and molecular biology services. The contract is to provide the Olink Explore HT platform to support the Sickle Cell Branch's efforts to detect proteomic biomarkers in individuals with sickle cell disease. The award does not have a set-aside designation. Psomagen has previously received other federal contract awards...
This federal contract award, valued at $11,844.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract is for the proteomic analysis of cerebrospinal fluid (CSF) samples from patients with amyotrophic lateral sclerosis (ALS) due to mutations in the CHCHD10 gene, using Olink's Explore HT technology. This purchase order-type contract has a firm fixed price and an ultimate completion date of June 24, 2025. Psomagen Inc. is a subsidiary of Macrogen, Inc. and has previously supported federal agencies, including the National Institutes of Health (NIH), Department of Agriculture (USDA), Food and Drug Administration (FDA), and Department of Veterans Affairs (VA), through prime contracts, subcontracts, and grants. The company holds two major federal indefinite delivery contracts, one with the NINDS for multi-omics data integration and analysis, and another with the USDA's Animal and Plant Health Inspection Service for Sanger sequencing services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 6/25/24 |